Skip to main content

Table 2 Patterns of management according to stroke mechanism. INDIA study-French Guiana

From: The epidemiology and management of stroke in French Guiana

Characteristics

All patients

N = 298 (%)

Ischemic stroke

N = 234 [78.5%] (%)

Intra-cerebral hemorrhage

N = 64 [21.4%] (%)

Thrombolysis*

32 (10.7)

32 (13.6)

0

During in-hospital stay

Medical treatment

 Antiplatelet therapy ± *

181 (60.9)

181 (77.6)

0

 Antihypertensive drug ±

76 (25.8)

61 (26.5)

15 (23.4)

 Heparin ±

129 (43.8)

122 (53)

7 (10.9)

 Injectable nicardipine ±

98 (33.2)

55 (23.8)

43 (67.1)

 Insulin ±

42 (14.1)

38 (16.3)

4 (6.20)

 Oral anti diabetics ±

16 (5.4)

16 (6.9)

0

 Urinary catheter

35 (11.7)

19 (8.1)

16 (25)

Other examinations

 CT scanner

253 (84.9)

193 (82.4)

60 (93.7)

 MRI

179 (6)

152 (64.9)

27 (42.1)

 Ultrasonography of the supra-aortic arteries

145 (48.6)

138 (58.9)

7 (10.9)

 Angio-scanner

169 (56.7)

139 (59.4)

30 (46.8)

 ECG±

294 (98.9)

233 (99.5)

61 (96.8)

 Holter±

113 (38.1)

110 (47.2)

3 (4.7)

 Trans-oesophageal ultrasonography

17 (5.7)

17 (7.2)

0

 Trans-thoracic echocardiography±

225 (75.7)

190 (81.2)

35 (55.5)

 MRI as first radiological examination

110 (36.9)

92 (39.3)

18 (28.1)

 Had both MRI and scanner

135 (45.3)

112 (47.9)

23 (35.9)

After discharge

Medical treatment

 Antiplatelet therapy±

197 (72.1)

196 (87.8)

1 (2)

 Anticoagulant therapy±

62 (22.7)

51 (22.8)

11 (22)

 Antihypertensive drug±

226 (82.7)

182 (81.6)

44 (88)

 Statin±

187 (68.5)

180 (80.7)

7 (14)

Non-medical treatment

 Speech therapy±

42 (15.9)

33 (12.5)

9 (18.7)

 Physical therapy±

136 (51.5)

106 (49.3)

30 (61.2)

Care pathways– admitted in …

 UNV

1

  

 Neurology±

181 (61.3)

144 (62)

37 (58.7)

 Short stay unit (UHCD)±

177 (60)

135 (45.7)

42 (66.6)

 ICU±

11 (3.7)

2 (0.86)

9 (14.2)

 Medecine±

65 (22)

53 (22.8)

12 (19)

 Otherunits±

43 (14.5)

37 (15.9)

6 (9.5)

Follow up checkup programmed ±

188 (73.4)

152 (73)

36 (75)

Follow up checkup done at hospital

139 (50.3)

109 (48.6)

30 (57.6)

Follow up checkup done: Examinations done after discharge

 MIR

33 (23.70)

19 (17.40)

14 (46.60)

 Arteriography

3 (2.10)

2 (1.80)

1 (0.72)

 Trans-esophagealultrasonography

10 (7.10)

10 (9.10)

0

 Transthoracicultrasonography

4 (2.80)

4 (3.60)

0

 Holter±

12 (8.70)

11 (10.10)

1 (3.30)

  1. ± Missing values:
  2. ∙ During care: Antiplatelet therapy = 1; Antihypertensive drug = 4; Heparin = 4; Injectable nicardipine = 3; Insulin = 1; Oral anti diabetics = 2; ECG = 1; Holter = 2; Trans-thoracic echocardiography = 1
  3. ∙ At discharge: Antiplatelet therapy = 25; Anticoagulant therapy = 25; Antihypertensive drug = 25; Statin = 25; Speech therapy = 34; Physical therapy = 34
  4. ∙ Care pathway: Neurology = 3; Short Stay Unit = 3; ICU = 3; Medicine = 3; other = 3; Follow up check-up programmed = 42; Follow up check-up done = 22
  5. ∙ Follow up checkupdone: Holter = 1
  6. *significant p value